Asymptomatic or mild COVID-19 infection in women prior to oocyte retrieval has no impact on embryo laboratory outcomes: a retrospective study

Abstract Background Few previous studies have addressed the impact of COVID-19 infection status on assisted reproductive technology outcomes. The purpose of this study was to assess whether COVID-19 infection affects ovulation induction outcomes and the laboratory outcomes of women undergoing assist...

Full description

Saved in:
Bibliographic Details
Main Authors: Yanhong Wu, Shenghao Wu, Weijue Su, Junzhao Zhao, Liangliang Ma
Format: Article
Language:English
Published: BMC 2025-02-01
Series:Journal of Ovarian Research
Subjects:
Online Access:https://doi.org/10.1186/s13048-025-01601-w
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823861702034194432
author Yanhong Wu
Shenghao Wu
Weijue Su
Junzhao Zhao
Liangliang Ma
author_facet Yanhong Wu
Shenghao Wu
Weijue Su
Junzhao Zhao
Liangliang Ma
author_sort Yanhong Wu
collection DOAJ
description Abstract Background Few previous studies have addressed the impact of COVID-19 infection status on assisted reproductive technology outcomes. The purpose of this study was to assess whether COVID-19 infection affects ovulation induction outcomes and the laboratory outcomes of women undergoing assisted reproductive technology treatment. Methods In total, 363 patients were divided into three groups: the COVID-19 infection group (group A, n = 49), the COVID-19 recovery group (group B, n = 119) and the COVID-19 non-infection group (group C, n = 195). Intergroup comparisons of baseline characteristics, stimulation characteristics and laboratory outcomes were performed. Results The Gn dosage in group A was significantly higher than those in groups B and C. The duration of Gn treatment was longer in group A than in group B. In group B, the number of high-quality blastocysts was lower than that in group C. The rates of blastocyst formation (42.56%) and high-quality blastocyst formation (12.05%) in group B were significantly lower than those in group A (51.51%; P = 0.003, 16.58%; P = 0.026) and C (48.20%; P = 0.005, 16.49%; P = 0.002). The high-quality blastocyst rate in group C (34.20%) was the highest and was different from that in group B (28.33%). The main risk factor for high-quality blastocyst formation according to multivariate logistic regression analysis was recovery from COVID-19 (0.599, 95% CI: 0.360–0.996; P = 0.048). Conclusion Asymptomatic or mild COVID-19 infection prior to oocyte retrieval may not has a significant negative effect on ovulation induction outcomes or laboratory outcomes, although the number of Gn days and dose of Gn may increase. In addition, we should pay attention to infertile women recovering from COVID-19 infection and be aware of the significant reduction in the number of high-quality blastocysts in this population.
format Article
id doaj-art-1d6e5556884f42e5804c3b2bf72f5d56
institution Kabale University
issn 1757-2215
language English
publishDate 2025-02-01
publisher BMC
record_format Article
series Journal of Ovarian Research
spelling doaj-art-1d6e5556884f42e5804c3b2bf72f5d562025-02-09T12:50:02ZengBMCJournal of Ovarian Research1757-22152025-02-011811910.1186/s13048-025-01601-wAsymptomatic or mild COVID-19 infection in women prior to oocyte retrieval has no impact on embryo laboratory outcomes: a retrospective studyYanhong Wu0Shenghao Wu1Weijue Su2Junzhao Zhao3Liangliang Ma4Department of Reproductive Center, Obstetrics and Gynecology, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical UniversityDepartment of Reproductive Center, Obstetrics and Gynecology, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical UniversityDepartment of Reproductive Center, Obstetrics and Gynecology, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical UniversityDepartment of Reproductive Center, Obstetrics and Gynecology, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical UniversityDepartment of Vascular Surgery, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical UniversityAbstract Background Few previous studies have addressed the impact of COVID-19 infection status on assisted reproductive technology outcomes. The purpose of this study was to assess whether COVID-19 infection affects ovulation induction outcomes and the laboratory outcomes of women undergoing assisted reproductive technology treatment. Methods In total, 363 patients were divided into three groups: the COVID-19 infection group (group A, n = 49), the COVID-19 recovery group (group B, n = 119) and the COVID-19 non-infection group (group C, n = 195). Intergroup comparisons of baseline characteristics, stimulation characteristics and laboratory outcomes were performed. Results The Gn dosage in group A was significantly higher than those in groups B and C. The duration of Gn treatment was longer in group A than in group B. In group B, the number of high-quality blastocysts was lower than that in group C. The rates of blastocyst formation (42.56%) and high-quality blastocyst formation (12.05%) in group B were significantly lower than those in group A (51.51%; P = 0.003, 16.58%; P = 0.026) and C (48.20%; P = 0.005, 16.49%; P = 0.002). The high-quality blastocyst rate in group C (34.20%) was the highest and was different from that in group B (28.33%). The main risk factor for high-quality blastocyst formation according to multivariate logistic regression analysis was recovery from COVID-19 (0.599, 95% CI: 0.360–0.996; P = 0.048). Conclusion Asymptomatic or mild COVID-19 infection prior to oocyte retrieval may not has a significant negative effect on ovulation induction outcomes or laboratory outcomes, although the number of Gn days and dose of Gn may increase. In addition, we should pay attention to infertile women recovering from COVID-19 infection and be aware of the significant reduction in the number of high-quality blastocysts in this population.https://doi.org/10.1186/s13048-025-01601-wAssisted reproductive technologyCOVID-19High-quality blastocystOocyte retrievalOvulation induction
spellingShingle Yanhong Wu
Shenghao Wu
Weijue Su
Junzhao Zhao
Liangliang Ma
Asymptomatic or mild COVID-19 infection in women prior to oocyte retrieval has no impact on embryo laboratory outcomes: a retrospective study
Journal of Ovarian Research
Assisted reproductive technology
COVID-19
High-quality blastocyst
Oocyte retrieval
Ovulation induction
title Asymptomatic or mild COVID-19 infection in women prior to oocyte retrieval has no impact on embryo laboratory outcomes: a retrospective study
title_full Asymptomatic or mild COVID-19 infection in women prior to oocyte retrieval has no impact on embryo laboratory outcomes: a retrospective study
title_fullStr Asymptomatic or mild COVID-19 infection in women prior to oocyte retrieval has no impact on embryo laboratory outcomes: a retrospective study
title_full_unstemmed Asymptomatic or mild COVID-19 infection in women prior to oocyte retrieval has no impact on embryo laboratory outcomes: a retrospective study
title_short Asymptomatic or mild COVID-19 infection in women prior to oocyte retrieval has no impact on embryo laboratory outcomes: a retrospective study
title_sort asymptomatic or mild covid 19 infection in women prior to oocyte retrieval has no impact on embryo laboratory outcomes a retrospective study
topic Assisted reproductive technology
COVID-19
High-quality blastocyst
Oocyte retrieval
Ovulation induction
url https://doi.org/10.1186/s13048-025-01601-w
work_keys_str_mv AT yanhongwu asymptomaticormildcovid19infectioninwomenpriortooocyteretrievalhasnoimpactonembryolaboratoryoutcomesaretrospectivestudy
AT shenghaowu asymptomaticormildcovid19infectioninwomenpriortooocyteretrievalhasnoimpactonembryolaboratoryoutcomesaretrospectivestudy
AT weijuesu asymptomaticormildcovid19infectioninwomenpriortooocyteretrievalhasnoimpactonembryolaboratoryoutcomesaretrospectivestudy
AT junzhaozhao asymptomaticormildcovid19infectioninwomenpriortooocyteretrievalhasnoimpactonembryolaboratoryoutcomesaretrospectivestudy
AT liangliangma asymptomaticormildcovid19infectioninwomenpriortooocyteretrievalhasnoimpactonembryolaboratoryoutcomesaretrospectivestudy